Literature DB >> 4154157

Reduced serum somatomedin activity in patients with chronic liver disease.

A Wu, D B Grant, J Hambley, A J Levi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4154157     DOI： 10.1042/cs0470359

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN： 0301-0538


× No keyword cloud information.
  7 in total

1.  Downregulation of the male-specific hepatic microsomal steroid 16 alpha-hydroxylase, cytochrome P-450UT-A, in rats with portal bypass. Relevance to estradiol accumulation and impaired drug metabolism in hepatic cirrhosis.

Authors:  E Cantrill; M Murray; I Mehta; G C Farrell
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

2.  Impaired growth hormone secretion in the adult population: relation to age and adiposity.

Authors:  D Rudman; M H Kutner; C M Rogers; M F Lubin; G A Fleming; R P Bain
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

3.  Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion.

Authors:  A Masuda; T Shibasaki; M Hotta; H Suematsu; K Shizume
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

4.  Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis.

Authors:  A Caufriez; P Reding; D Urbain; J Golstein; G Copinschi
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

5.  IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture.

Authors:  V J Lara-Diaz; I Castilla-Cortazar; I Martín-Estal; M García-Magariño; G A Aguirre; J E Puche; R G de la Garza; L A Morales; U Muñoz
Journal:  J Physiol Biochem       Date:  2017-01-26       Impact factor: 4.158

6.  Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C.

Authors:  Agnieszka Adamek; Aldona Kasprzak; Agnieszka Seraszek; Hanna Mikoś; Aleksandra Bura; Iwona Mozer-Lisewska
Journal:  Contemp Oncol (Pozn)       Date:  2012-07-06

Review 7.  Is insulin-like growth factor-1 involved in Parkinson's disease development?

Authors:  Inma Castilla-Cortázar; Gabriel A Aguirre; Giovana Femat-Roldán; Irene Martín-Estal; Luis Espinosa
Journal:  J Transl Med       Date:  2020-02-11       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.